KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Invested Capital (2016 - 2025)

Historic Invested Capital for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $847.4 million.

  • Evolent Health's Invested Capital fell 1842.08% to $847.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $847.4 million, marking a year-over-year decrease of 1842.08%. This contributed to the annual value of $1.2 billion for FY2024, which is 983.66% up from last year.
  • Latest data reveals that Evolent Health reported Invested Capital of $847.4 million as of Q3 2025, which was down 1842.08% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Invested Capital ranged from a high of $1.2 billion in Q4 2024 and a low of $611.2 million during Q1 2022
  • Over the past 5 years, Evolent Health's median Invested Capital value was $1.0 billion (recorded in 2024), while the average stood at $908.9 million.
  • In the last 5 years, Evolent Health's Invested Capital plummeted by 4370.23% in 2021 and then skyrocketed by 8352.85% in 2023.
  • Evolent Health's Invested Capital (Quarter) stood at $693.6 million in 2021, then increased by 23.9% to $859.4 million in 2022, then grew by 24.24% to $1.1 billion in 2023, then increased by 9.84% to $1.2 billion in 2024, then decreased by 27.75% to $847.4 million in 2025.
  • Its Invested Capital was $847.4 million in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.